- Do you, or did you, own shares of Spectrum Pharmaceuticals, Inc. (NASDAQ GS: SPPI)?
- Did you purchase your shares between December 16, 2015 and September 16, 2016, inclusive?
- Did you lose money in your investment?
Please contact Rigrodsky & Long, P.A. (“R & L”) to schedule a free consultation. You may call us or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.
R & L is investigating claims brought in a securities fraud class action complaint against Spectrum Pharmaceuticals, Inc. ("Spectrum") concerning whether Spectrum and certain of the Company’s directors and/or officers made materially false and misleading statements and failed to disclose materially adverse facts during the period December 16, 2015 and September 16, 2016 (the “Class Period”), concerning the Company’s business, operations and prospects. These misrepresentations and omissions artificially inflated the price of the Company's stock throughout the Class Period.